Press Releases

Date Title and Summary
Toggle Summary Accuray Announces Results for Third Quarter of Fiscal 2009
Record Total Revenue for Quarter SUNNYVALE, Calif ., May 5 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the third quarter of fiscal 2009, ended March 28, 2009 .
Toggle Summary Accuray Announces Results for Third Quarter of Fiscal 2011
SUNNYVALE, Calif., May 5, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the third quarter of fiscal year 2011, ended March 31, 2011 . For the third quarter of fiscal 2011, Accuray reported
Toggle Summary Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023
SUNNYVALE, Calif. , June 15, 2023 /PRNewswire/ -- The global Accuray Incorporated (NASDAQ: ARAY) team is proud to announce that president and CEO Suzanne Winter has been recognized by The Healthcare Technology Report as one of the Top 50 Healthcare Technology CEOs of 2023.
Toggle Summary Accuray Announces Suzanne Winter, President, Promoted to President and CEO; Joshua Levine Will Retire as CEO and Board Member
Accuray Also Announces Chief Financial Officer, Ali Pervaiz SUNNYVALE, Calif. , April 27, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Suzanne Winter , President, will succeed Joshua Levine as the company's Chief Executive Officer, effective July 1, 2022 .     Mr.
Toggle Summary Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration
SUNNYVALE, Calif. , Nov. 1, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo ® C radiation therapy system for the Type B market has been submitted to the Chinese National Medical Products Administration
Toggle Summary Accuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller
SUNNYVALE, Calif. , June 15, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Franco N. Palomba has joined the company as vice president, chief accounting officer & controller. Mr. Palomba will be responsible for the controllership function, including the global
Toggle Summary Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors
SUNNYVALE, Calif. , Feb. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Byron C. Scott , M.D., MBA to the company's Board of Directors, effective as of February 12, 2021 . Dr. Scott brings significant experience as a physician executive with
Toggle Summary Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors
SUNNYVALE, Calif. , Sept. 12, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) strengthened its Board of Directors with the appointment of James (Jim) M. Hindman , effective as of September 6, 2019 , and expanding the company's Board to nine members. Mr.
Toggle Summary Accuray Appoints Jack Goldstein, Ph.D. to Board of Directors
SUNNYVALE, Calif., May 26, 2010 /PRNewswire via COMTEX/ --Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today the appointment of Jack Goldstein, Ph.D. as a member of the company's Board of Directors, effective immediately. Dr.
Toggle Summary Accuray Appoints Jean-Philippe Pignol, M.D., Ph.D. as Chief Medical & Technology Officer
SUNNYVALE, Calif. , April 26, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY ) announced today the appointment of Jean-Philippe Pignol , M.D., Ph.D. as its chief medical & technology officer, effective as of April 15, 2021 . In this new role, Dr.

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.